Stonepine Capital Management LLC 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 5:06 pm Sale |
2020-12-31 | 13G | Interpace Biosciences, Inc. IDXG |
Stonepine Capital Management LLC | 0 0.000% |
-277,277 (Position Closed) |
Filing |
| 2020-09-11 4:34 pm Purchase |
2020-09-03 | 13G | Interpace Biosciences, Inc. IDXG |
Stonepine Capital Management LLC | 277,277 6.900% |
169,517 (+157.31%) |
Filing |